Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

85 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
The human prostatic cancer cell line LNCaP and its derived sublines: an in vitro model for the study of androgen sensitivity.
van Steenbrugge GJ, van Uffelen CJ, Bolt J, Schröder FH. van Steenbrugge GJ, et al. Among authors: bolt j. J Steroid Biochem Mol Biol. 1991;40(1-3):207-14. doi: 10.1016/0960-0760(91)90184-7. J Steroid Biochem Mol Biol. 1991. PMID: 1958522 Review.
Transformation (4S to 5S) of the nuclear estrogen receptor is reversible but not accompanied by a change in the affinity for DNA.
de Boer W, Bolt J. de Boer W, et al. Among authors: bolt j. J Steroid Biochem. 1988 Dec;31(6):931-7. doi: 10.1016/0022-4731(88)90335-4. J Steroid Biochem. 1988. PMID: 3199829
Androgens stimulate both growth rate and epidermal growth factor receptor activity of the human prostate tumor cell LNCaP.
Schuurmans AL, Bolt J, Mulder E. Schuurmans AL, et al. Among authors: bolt j. Prostate. 1988;12(1):55-63. doi: 10.1002/pros.2990120108. Prostate. 1988. PMID: 3258066
Androgens and transforming growth factor beta modulate the growth response to epidermal growth factor in human prostatic tumor cells (LNCaP).
Schuurmans AL, Bolt J, Mulder E. Schuurmans AL, et al. Among authors: bolt j. Mol Cell Endocrinol. 1988 Nov;60(1):101-4. doi: 10.1016/0303-7207(88)90124-4. Mol Cell Endocrinol. 1988. PMID: 3265111
Regulation of growth and epidermal growth factor receptor levels of LNCaP prostate tumor cells by different steroids.
Schuurmans AL, Bolt J, Voorhorst MM, Blankenstein RA, Mulder E. Schuurmans AL, et al. Among authors: bolt j. Int J Cancer. 1988 Dec 15;42(6):917-22. doi: 10.1002/ijc.2910420622. Int J Cancer. 1988. PMID: 3263955
Structure and function of the androgen receptor.
Brinkmann AO, Klaasen P, Kuiper GG, van der Korput JA, Bolt J, de Boer W, Smit A, Faber PW, van Rooij HC, Geurts van Kessel A, et al. Brinkmann AO, et al. Among authors: bolt j. Urol Res. 1989;17(2):87-93. doi: 10.1007/BF00262026. Urol Res. 1989. PMID: 2734982
Androgen receptor-mediated growth and epidermal growth factor receptor induction in the human prostate cell line LNCaP.
Schuurmans AL, Bolt J, Mulder E. Schuurmans AL, et al. Among authors: bolt j. Urol Int. 1989;44(2):71-6. doi: 10.1159/000281473. Urol Int. 1989. PMID: 2728128
The human prostatic carcinoma cell line LNCaP and its derivatives. An overview.
van Steenbrugge GJ, Groen M, van Dongen JW, Bolt J, van der Korput H, Trapman J, Hasenson M, Horoszewicz J. van Steenbrugge GJ, et al. Among authors: bolt j. Urol Res. 1989;17(2):71-7. doi: 10.1007/BF00262024. Urol Res. 1989. PMID: 2660395 Review.
Stimulatory effects of antiandrogens on LNCaP human prostate tumor cell growth, EGF-receptor level and acid phosphatase secretion.
Schuurmans AL, Bolt J, Veldscholte J, Mulder E. Schuurmans AL, et al. Among authors: bolt j. J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):849-53. doi: 10.1016/0960-0760(90)90431-j. J Steroid Biochem Mol Biol. 1990. PMID: 2149505
Antiproliferative effects of suramin on androgen responsive tumour cells.
Berns EM, Schuurmans AL, Bolt J, Lamb DJ, Foekens JA, Mulder E. Berns EM, et al. Among authors: bolt j. Eur J Cancer. 1990 Apr;26(4):470-4. doi: 10.1016/0277-5379(90)90018-o. Eur J Cancer. 1990. PMID: 2141513
85 results
Jump to page
Feedback